Forte Biosciences
FBRX
FBRX was delisted on the 26th of August, 2026.
62 hedge funds and large institutions have $273M invested in Forte Biosciences in 2021 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 7 closing their positions.
186% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 7
67% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 12
27% more funds holding
Funds holding: 49 → 62 (+13)
6.43% less ownership
Funds ownership: 65.41% → 58.98% (-6.4%)
19% less capital inflows, than outflows
Capital inflows: $63.4M | Capital outflows: $78.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$13.6M |
| 2 |
Perceptive Advisors
New York
|
+$11M |
| 3 |
SCM
Suvretta Capital Management
New York
|
+$9.01M |
| 4 |
ACM
Altium Capital Management
New York
|
+$4.41M |
| 5 |
Millennium Management
New York
|
+$3.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$50.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$8.04M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$7.49M |
| 4 |
Credit Suisse
Zurich,
Switzerland
|
-$3.1M |
| 5 |
Maven Securities
St Helier,
Jersey
|
-$3.04M |
FBRX Hedge Fund Activity: Q1 2021 in Review
62 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q1 2021, worth a combined $273M — down 11% from $306M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new FBRX positions and 7 closed out — a net gain of 13 holders — while 20 added to existing stakes and 12 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $13.6M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $50.5M.
- 62 institutional investors held Forte Biosciences (FBRX) as of Q1 2021, up from 49 in Q4 2020.
- Funds reported $273M of Forte Biosciences stock for Q1 2021, down 11% quarter-over-quarter.
- 20 funds opened new Forte Biosciences positions in Q1 2021 and 7 closed out, a net change of +13 holders.
- The largest Forte Biosciences buyer in Q1 2021 was Point72 Asset Management, an estimated $13.6M added.
- The largest Forte Biosciences seller in Q1 2021 was ArrowMark Colorado Holdings, an estimated $50.5M sold.
Based on aggregated 13F filings for Q1 2021.